Insmed Inc [INSM] stock is trading at $71.68, up 2.80%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INSM shares have gain 6.15% over the last week, with a monthly amount drifted -1.32%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on May 13, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $105. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on February 25, 2025, and set its price target to $100. On April 23, 2024, Truist initiated with a Buy rating and assigned a price target of $48 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $42 on February 15, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $55 as its price target on December 08, 2023. In a note dated July 26, 2023, Guggenheim initiated an Buy rating and provided a target price of $50 on this stock.
Insmed Inc [INSM] stock has fluctuated between $53.69 and $84.91 over the past year. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $71.68 at the most recent close of the market. An investor can expect a potential return of 53.46% based on the average INSM price forecast.
Analyzing the INSM fundamentals
Insmed Inc [NASDAQ:INSM] reported sales of 381.03M for the trailing twelve months, which represents a growth of 22.94%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.3%, Pretax Profit Margin comes in at -2.65%, and Net Profit Margin reading is -2.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -4.47 and Total Capital is -0.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of11.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 70.07 points at the first support level, and at 68.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 72.82, and for the 2nd resistance point, it is at 73.95.
Ratios To Look Out For
For context, Insmed Inc’s Current Ratio is 5.86. Also, the Quick Ratio is 5.44, while the Cash Ratio stands at 1.69. Considering the valuation of this stock, the price to sales ratio is 34.26, the price to book ratio is 131.49.
Transactions by insiders
Recent insider trading involved Lewis William, Officer, that happened on Jun 02 ’25 when 6830.0 shares were purchased. Officer, Smith Michael Alexander completed a deal on May 30 ’25 to buy 26327.0 shares. Meanwhile, Former Officer Wise John Drayton bought 6691.0 shares on May 29 ’25.
